Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENSN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,255
Award facts
- Contract value 100% obligated
- $4,255.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $4,255.34 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on December 22, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group was selected as a regional prime vendor contractor under this program, holding a single-award IDC valued at up to $499,999,999 through December 31, 2036. This award includes no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement.
Under this delivery order and the broader PPV-G GEN V contract, DMS Pharmaceutical Group supplies an extensive range of pharmaceutical products and medical consumables to support DoD healthcare operations, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The company's product portfolio encompasses critical therapeutic categories ranging from oncology treatments and immunosuppressants to emergency medications, vaccines, and routine pharmaceuticals. The delivery order will be performed at the company's Park Ridge, Illinois location, with all work funded by the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DU26FENSN?
SPE2DU26FENSN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DU26FENSN worth?
The government has obligated $4,255 on SPE2DU26FENSN.
Is contract SPE2DU26FENSN an order under another contract?
Yes. SPE2DU26FENSN is a delivery order under SPE2DU25D9420, an indefinite delivery contract.
Was contract SPE2DU26FENSN competed?
The extent of competition for SPE2DU26FENSN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award